3 Einträge |
Seite 1 / 1
![]() |
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. |
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
PMID: 29146401 |
Personal UVR exposure of farming families in four European countries. |
Bodekær M, Harrison GI, Philipsen P, Petersen B, Triguero-Mas M, Schmalwieser AW, Rogowski-Tylman M, Dadvand P, Lesiak A, Narbutt J, Eriksen P, Heydenreich J, Nieuwenhuijsen M, Thieden E, Young AR, Wulf HC |
Journal of photochemistry and photobiology. B, Biology. 2015 Oct 9. pii: S1011-1344(15)00323-1. doi: 10.1016/j.jphotobiol.2015.10.002 |
PMID: 26492279 |
Discharge Age and Weight for Very Preterm Infants in Six Countries: 2012-2020. |
Edwards EM, Greenberg LT, Horbar JD, Gagliardi L, Adams M, Berger A, Leitao S, Luyt K, Ehret DEY, Rogowski JA |
Neonatology. 2023 Jan 17. doi: 10.1159/000528013. pii: 000528013 |
PMID: 36649689 |
3 Einträge |
Seite 1 / 1
![]() |